Shanghai Fosun Pharmaceutical Group Co Ltd ($2196) - buy or sell? Stock discussion, ideas, forum

Shanghai Fosun Pharmaceutical Group Co Ltd

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$2196	HKEx Main Board	CNE100001M79	Code: 2196

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 2196 stock

Share your investment idea or question on Shanghai Fosun Pharmaceutical Group Co Ltd stock:

Latest twits on Shanghai Fosun Pharmaceutical Group Co Ltd (2196)

No twits yet. Be the first to post!

Have a question about 2196? Ask and other investors will be eager to help you.

Have an idea about 2196? Share it with other investors.

Shanghai Fosun Pharmaceutical Group Co Ltd news

29/03/2016 Shanghai Fosun Pharmaceutical Group Co Ltd reports 22.5% EBITDA growth and 4.7% Revenue growth

Shanghai Fosun Pharmaceutical Group Co Ltd stock price chart

Shanghai Fosun Pharmaceutical Group Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	4,529	6,433	7,278
EBITDA	277.6	1,508	1,923
Net income	863.7	1,166	1,564
CAPEX	339.2	796.8	1,161
Debt	4,689	6,094	5,655
Cash	3,120	2,428	4,172

Shanghai Fosun Pharmaceutical Group Co Ltd news

29/03/2016 Shanghai Fosun Pharmaceutical Group Co Ltd reports 22.5% EBITDA growth and 4.7% Revenue growth

About Shanghai Fosun Pharmaceutical Group Co Ltd

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.